On Aug. 8, 2018, the Food and Drug Administration approved mogamulizumab-kpkc (Poteligeo, Kyowa Kirin, Inc.) for adult patients with relapsed […]
The post Poteligeo Approved for Treatment of Mycosis Fungoides or Sézary syndrome appeared first on .
Latest Images
Trending Articles
More Pages to Explore .....